Genome Medical Stock
Genome Medical is a network of genomics services experts using telemedicine to integrate genomic insights into everyday health care.
Sign up for SecondMarket™ to view the market and buy or sell Genome Medical Stock
Buy + SellGenome Medical Funding
Sign up to gain insights into Genome Medical funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Sep 10, 2024 | Series D | 15.28M | ||
| Sep 10, 2024 | Series D | 28.01M | ||
| Sep 10, 2024 | Series D | 5.86M | ||
| Sep 10, 2024 | Series D | 21.19M | ||
| Sep 10, 2024 | Series D | 5.00M | ||
| Aug 30, 2021 | Series C | 60.00M | ||
| Apr 06, 2020 | Series B | 14.41M | ||
| May 30, 2019 | Series B | 23.00M | ||
| Dec 22, 2017 | Series A | 3.00M | ||
| Nov 27, 2017 | Series A | 8.00M | ||
| Mar 14, 2017 | Series A | 8.10M | ||
| Nov 09, 2016 | Series Seed | 2.26M |
See Genome Medical Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Genome Medical Stock Valuation + Share Prices
View real-time Tape D™ data on Genome Medical stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Genome Medical Management Team
Chief Medical Officer
Brian Kirmse
Co-Founder
Robert C Green
CEO, Director
Jill Davies
Chief Clinical Officer
Kiley Johnson
Director
Shaun Rodriguez
Chief Product Officer
Andi Hila
CFO
Mark Sylvester
Director
Alex Parker
Director
Russell Glass
Co-Founder
Randy Scott
Genome Medical Major Investors
AVG Ventures LP
LRVHealth
Illumina Ventures
Avestria Ventures
HealthInvest Equity Partners
GE Ventures
Manatt Venture Fund
Flywheel Ventures
Google Ventures (GV)
Amgen Ventures
Casdin Capital
Echo Health Ventures
Revelation Partners
Canaan Partners
Illumina Ventures
Kaiser Permanente Ventures
Dreamers
Samsung Catalyst Fund
Perceptive Advisors
Learn More About Genome Medical Stock
Buy Genome Medical Stock
01Genome Medical stock does not trade on public stock exchanges. Genome Medical stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Genome Medical stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Genome Medical Stock
02Genome Medical Stock does not trade on public stock exchanges. In order to sell Genome Medical shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Genome Medical Stock Price
03Genome Medical does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Genome Medical share price and other valuable private market data.
Read more about secondary market private company stock prices:
Genome Medical Stock Ticker Symbol
04There is no ticker symbol for Genome Medical stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Genome Medical Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Genome Medical stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Genome Medical Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Genome Medical stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Genome Medical Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Genome Medical IPO
08Genome Medical is a private company and has not had an IPO. There is currently no Genome Medical IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Genome Medical IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Genome Medical Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
